Shingo Miyamoto

4.6k total citations · 2 hit papers
118 papers, 3.7k citations indexed

About

Shingo Miyamoto is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shingo Miyamoto has authored 118 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 37 papers in Molecular Biology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shingo Miyamoto's work include Lung Cancer Treatments and Mutations (23 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Research Studies (9 papers). Shingo Miyamoto is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Research Studies (9 papers). Shingo Miyamoto collaborates with scholars based in Japan, United States and United Kingdom. Shingo Miyamoto's co-authors include Kenneth M. Yamada, Steven K. Akiyama, Hidemi Teramoto, J. Silvio Gutkind, Takuji Tanaka, Hitoo Nakano, Akira Murakami, Yumiko Yasui, Hajime Ohigashi and Daniel W. Rosenberg and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Shingo Miyamoto

115 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergistic Roles for Receptor Occupancy and Aggregation in Integrin Transmembrane Function

1995 781 citations Shingo Miyamoto, Kenneth M. Yamada et al. profile →
Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.

1996 662 citations Shingo Miyamoto, Hidemi Teramoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shingo Miyamoto Japan	29	1.4k	1.1k	888	793	534	118	3.7k
Jianfeng Chen China	30	1.4k 1.0×	659 0.6×	436 0.5×	426 0.5×	396 0.7×	105	3.2k
Robert A. Swerlick United States	36	1.9k 1.3×	1.2k 1.0×	814 0.9×	427 0.5×	552 1.0×	136	6.0k
John A. Wilkins Canada	37	2.5k 1.7×	913 0.8×	401 0.5×	724 0.9×	379 0.7×	130	5.4k
Risto Renkonen Finland	38	2.5k 1.8×	1.4k 1.2×	784 0.9×	336 0.4×	417 0.8×	195	5.2k
Toshihide Mimura Japan	32	1.2k 0.8×	577 0.5×	356 0.4×	374 0.5×	291 0.5×	127	3.2k
Ilona Kovalszky Hungary	40	2.1k 1.5×	287 0.3×	932 1.0×	1.2k 1.5×	1.0k 1.9×	182	4.8k
Jean Rosenbaum France	45	2.0k 1.4×	303 0.3×	923 1.0×	571 0.7×	772 1.4×	150	5.3k
Wolfgang Bergmeier United States	47	1.5k 1.0×	1.1k 1.0×	494 0.6×	358 0.5×	329 0.6×	139	6.8k
Fabrizio Marcucci Italy	36	1.2k 0.8×	1.1k 0.9×	1.0k 1.1×	127 0.2×	406 0.8×	141	4.6k
Gaston Vilaire United States	28	1.3k 0.9×	1.7k 1.5×	236 0.3×	386 0.5×	348 0.7×	46	4.1k

Countries citing papers authored by Shingo Miyamoto

Since Specialization

Citations

This map shows the geographic impact of Shingo Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Miyamoto more than expected).

Fields of papers citing papers by Shingo Miyamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Miyamoto. The network helps show where Shingo Miyamoto may publish in the future.

Co-authorship network of co-authors of Shingo Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Miyamoto. A scholar is included among the top collaborators of Shingo Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Miyamoto. Shingo Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakabayashi, Kazuhiko, Noriko Ito, Kohei Miyata, et al.. (2025). Culture Medium Enriched with Ultrafine Carbon Monoxide Bubbles Enhances In Vitro Blastocyst Formation of In Vivo-Fertilized Mouse Zygotes. Antioxidants. 14(6). 684–684.

Udagawa, Hibiki, Shingo Matsumoto, Hiroki Izumi, et al.. (2024). Efficacy of immunotherapy in first-line treatment for non-small cell lung cancer with HER2 mutation: Results from LC-SCRUM-Asia.. Journal of Clinical Oncology. 42(16_suppl). 8629–8629. 1 indexed citations

Kitagawa, Shingo, Yoshitaka Zenke, Kiyotaka Yoh, et al.. (2023). 236TiP Large-scale prospective observational study to develop a liquid-based detection system of minimal residual disease (MRD): LC-SCRUM-MRD. Annals of Oncology. 34. S275–S276. 1 indexed citations

Zenke, Yoshitaka, Kiyotaka Yoh, Shingo Kitagawa, et al.. (2023). 1282P Concordance of PD-L1 expression between biopsy and matched surgical specimen in early-stage non-small cell lung cancer: LC-SCRUM-Advantage/MRD. Annals of Oncology. 34. S740–S741. 1 indexed citations

Sakurai, Hiroki, Mitsunori Miyashita, Tatsuya Morita, et al.. (2021). Comparison between patient-reported and clinician-reported outcomes: Validation of the Japanese version of the Integrated Palliative care Outcome Scale for staff. Palliative & Supportive Care. 19(6). 702–708. 11 indexed citations

Zenke, Yoshitaka, Shingo Matsumoto, Naoki Furuya, et al.. (2020). Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).. Journal of Clinical Oncology. 38(15_suppl). 9589–9589. 10 indexed citations

Miyamoto, Shingo, Koichi Azuma, Hidenobu Ishii, et al.. (2020). Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer. JAMA Oncology. 6(7). e201250–e201250. 37 indexed citations

Hirose, Yusuke, Mamiko Onuki, Yoshiyuki Ishii, et al.. (2018). ヒトパピローマウイルスの宿主内変異はウイルスゲノムにおけるAPOBECシグネチャー変異誘発を明らかにする【JST・京大機械翻訳】. Journal of Virology. 92(12). 17–18. 22 indexed citations

Mori, Masanori, Tatsuya Morita, Naosuke Yokomichi, et al.. (2018). Validation of the Edmonton Symptom Assessment System: Ascites Modification. Journal of Pain and Symptom Management. 55(6). 1557–1563. 5 indexed citations

10.

Matsumoto, Koji, Takashi Mimura, Tetsuya Ishikawa, et al.. (2017). Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study. International Journal of Clinical Oncology. 23(3). 514–521. 11 indexed citations

11.

Kodama, Chikaaki, Koichi Nakayama, Takayuki Kotani, et al.. (2013). Self-Aligned Double and Quadruple Patterning-aware grid routing with hotspots control. 267–272. 34 indexed citations

12.

Miyamoto, Shingo, Masako Nakanishi, & Daniel W. Rosenberg. (2013). Suppression of colon carcinogenesis by targeting Notch signaling. Carcinogenesis. 34(10). 2415–2423. 28 indexed citations

13.

Ota, Toshiyuki, Keiko Doi, Takahiro Fujimoto, et al.. (2012). KRAS up-regulates the expression of miR-181a, miR-200c and miR-210 in a three-dimensional-specific manner in DLD-1 colorectal cancer cells.. PubMed. 32(6). 2271–5. 47 indexed citations

14.

Nakanishi, Masako, Antoine Ménoret, Takuji Tanaka, et al.. (2011). Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity. Cancer Prevention Research. 4(8). 1198–1208. 71 indexed citations

15.

Shirota, Kyoko, et al.. (2011). Metronomic doxifluridine chemotherapy combined with the anti‐angiogenic agent TNP‐470 inhibits the growth of human uterine carcinosarcoma xenografts. Cancer Science. 102(8). 1545–1552. 9 indexed citations

16.

Kawarabayashi, Tatsuhiko, et al.. (2010). Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft. Cancer Science. 102(2). 452–459. 9 indexed citations

17.

Kim, Mi-Hye, Shingo Miyamoto, Shigeyuki Sugie, et al.. (2008). A tobacco-specific carcinogen, NNK, enhances AOM/DSS-induced colon carcinogenesis in male A/J mice.. PubMed. 22(5). 557–63. 10 indexed citations

18.

Miyamoto, Shingo & Eisuke Mekada. (2004). [Biological behavior of ovarian cancer].. PubMed. 62 Suppl 10. 458–62. 1 indexed citations

19.

Katz, Ben‐Zion, Shingo Miyamoto, Hidemi Teramoto, et al.. (2002). Direct transmembrane clustering and cytoplasmic dimerization of focal adhesion kinase initiates its tyrosine phosphorylation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1592(2). 141–152. 30 indexed citations

20.

Miyamoto, Shingo, et al.. (1992). The characteristics of erythrocyte Na+ transport systems in normal pregnancy and pregnancy-induced hypertension. Journal of Hypertension. 10(4). 367–372. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact